You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 28, 2024

Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2020)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for JANSSEN PHARMACEUTICALS, INC. v. MYLAN LABORATORIES LIMITED (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-03-21 148 Redacted Document Patent-In-Suit 693 Patent U.S. Patent No. 10,143,693 Asserted Claims…obviousness-type double patenting over claims 1-16 of US Patent No. 9,439,906 (the 906 Patent) in view of Osborne… for obviousness-type double patenting over the 906 Patent (the patent that issued from the 519 Publication… and an earlier patent incorporated by reference in the 693 Patent, the 693 Patent disclosure would…24 (Berger). IV. THE 693 PATENT 19. The 693 Patent “relates to a method for treating External link to document
2023-03-21 149 Redacted Document of the patent-in-suit. That is why U.S. Patent No. 10,143,693 (“the ’693 patent”) thwarts … such patents. Examining the actual prosecution history of the patent reveals what the patent truly…JAMA to the patent office when prosecuting the ’693 patent. Without JAMA before the patent examiner, …this patent in the first place. Because when Janssen’s patent was rejected by the patent office…obtained the ’693 patent by telling the patent office that it was nothing like the ’906 patent because the External link to document
2023-03-21 150 Redacted Document Patent-In-Suit 693 Patent U.S. Patent No. 10,143,693 Asserted Claims…including Dr. Forrest’s own patents—the structural features in the 693 Patent are entirely adequate to…It is a bedrock principle of patent law that the claims of a patent define the invention to which the…there are “two elements of a simple patent case, construing the patent and determining whether infringement…) 519 Publication PTX-115 United States Patent Application Publication DTX External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.